Furthermore, several papers described the in vivo transplantation of precursors engineered to overexpress the glial cell line-derived neurotrophic factor (GDNF) and their efficacy in ameliorating the pathological phenotype of rodent models of ALS [98,99,100] and PD [101,102]. This evidence concerns the gene GDNF and amyotrophic lateral sclerosis.